Market Tracker

11/26 6:05pm ET

Albany Molecular Research Inc (NASDAQ:AMRI)

15.85
Data as of Nov 26
 +0.35 / +2.26%
Today’s Change
9.71
Today|||52-Week Range
23.95
+57.24%
Year-to-Date
No recent news for Albany Molecular Research Inc.

Today’s Trading

Previous close15.50
Today’s open15.56
Day’s range15.48 - 15.90
Volume287,234
Average volume (3 months)482,126
Market cap$505.4M
Dividend yield--
Data as of 3:59pm ET, 11/26/2014

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-3.57%
Earnings growth (next 5 years)+19.40%
Revenue growth (last year)+8.77%
P/E ratio158.5
Price/Sales1.26
Price/Book1.99

Competitors

 Today’s
change
Today’s
% change
EXELExelixis Inc+0.04+2.33%
ARWRArrowhead Research C...-0.06-1.03%
LXRXLexicon Pharmaceutic...+0.01+1.25%
FLXNFlexion Therapeutics...+0.51+2.97%
Data as of 4:00pm ET, 11/26/2014

Financials

Next reporting dateFebruary 9, 2015
EPS forecast (this quarter)$0.32
Annual revenue (last year)$246.6M
Annual profit (last year)$12.7M
Net profit margin5.14%

Profile

Sector
Health Services
Industry
Services to the Health Industry
President, Chief Executive Officer &
Director
William S. Marth
Chief Financial Officer, Treasurer &
SVP
Michael Nolan
Corporate headquarters
Albany, New York

Forecasts